Medical Research

Fuatilia
Microscopic illustration of T cells with SLAMF6 receptors and blocking antibodies fighting cancer cells.
Picha iliyoundwa na AI

Study identifies SLAMF6 as a self-activating brake on anti-cancer T cells, pointing to a new immunotherapy target

Imeripotiwa na AI Picha iliyoundwa na AI Imethibitishwa ukweli

A research team led by Université de Montréal immunologist André Veillette reports that the immune receptor SLAMF6 can inhibit T cells by activating through interactions on the T cell surface itself, a mechanism the authors say could help explain why some patients fail to respond—or later stop responding—to checkpoint-based cancer immunotherapies. In the same study, the researchers describe monoclonal antibodies designed to block SLAMF6’s self-interaction, which boosted T-cell activity in laboratory tests and strengthened anti-tumor responses in mouse experiments.

A copper-based drug has shown potential to reduce toxic protein buildup and improve memory in laboratory models of Alzheimer’s disease. Researchers at Monash University found that the compound Cu(ATSM) enhanced the brain’s waste-clearing mechanisms. The results were published in ACS Chemical Neuroscience.

Imeripotiwa na AI

Chess featured prominently at a clinical symposium on Brain-Computer Interface technology held in Shenzhen. FIDE Treasurer Zhu Chen attended the event, highlighting the game's potential in advancing medical research.

A study of 440 participants from the Women’s Interagency HIV Study found that accelerated epigenetic aging in monocytes—an immune cell type—tracked more closely with emotional and cognitive depression symptoms such as hopelessness and loss of pleasure than with physical symptoms like fatigue. The work, published in The Journals of Gerontology: Series A, adds evidence that cell-type-specific aging measures could contribute to future biological tools to complement symptom-based depression screening, though researchers say more validation is needed before clinical use.

Imeripotiwa na AI Imethibitishwa ukweli

Engineers at Washington University in St. Louis report that while single abnormal cells can mechanically probe roughly 10 microns beyond what they directly touch, groups of epithelial cells can combine forces through collagen to sense features more than 100 microns away—an effect the researchers say could help explain how cancer cells navigate tissue.

A study shows that advanced lung cancer patients receiving immunochemotherapy earlier in the day survive longer. A Hong Kong medical expert says the discovery opens possibilities for optimal treatment times, though more research is needed. The research was led by academics from Hunan Cancer Hospital in mainland China and supported by the Chinese University of Hong Kong’s faculty of medicine.

Imeripotiwa na AI

Researchers in Brazil have uncovered how pancreatic cancer uses a protein called periostin to invade nerves and spread early. This discovery explains the disease's aggressiveness and suggests new treatment targets. The findings, published in Molecular and Cellular Endocrinology, highlight the tumor's ability to remodel surrounding tissue.

 

 

 

Tovuti hii inatumia vidakuzi

Tunatumia vidakuzi kwa uchambuzi ili kuboresha tovuti yetu. Soma sera ya faragha yetu kwa maelezo zaidi.
Kataa